As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate in an effort to ensure that they were not left behind.
With 92% of global companies saying that transforming digital communications is critical to address the current challenges, agencies need to have a clear and effective plan to connect with their clients through the increasingly important digital lens.
Educational, non-promotional content is key to pharma engagement strategies, and digital technology will play a fundamental role in sustaining, and even improving, the quality of that content while enabling HCPs to focus more of their time and resources on their patients.
This supplement looks at the following key issues:
View online PME Supplement August 2020
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....